ADH-1 trifluoroacetate
ADH-1 trifluoroacetate (Exherin) is a cyclic pentapeptide that selectively inhibits N-cadherin, disrupting tumor vasculature and inducing apoptosis. It is used in cancer research for its antiangiogenic properties, studied in both in vitro models and in vivo xenograft experiments targeting N-cadherin-expressing tumors.
Product Specifications
Product Name Alternative
ADH 1, ADH 1 Trifluoroacetate, ADH 1 trifluoroacetate, ADH1, ADH-1, ADH1 trifluoroacetate, ADH1 Trifluoroacetate, ADH-1 Trifluoroacetate, Exherin trifluoroacetate, Exherin Trifluoroacetate, Inhibitor, N-cadherin, inhibit
Field of Research
Metabolism Research, Signal Transduction
Purity
90.08% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (2.92 mM) ; DMSO:43 mg/mL (62.8 mM)
Molecular Weight
684.71
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-12109R-BF555 100 µL
P2X5b Polyclonal Antibody, AbBy Fluor™ 555 Conjugated
Sign In for Pricing
View Details 
046514 100 µg
PROS1/Protein S, Recombinant, Human, His-Tag discontinued
Sign In for Pricing
View Details